FDA Warns of Unapproved Marijuana-Based Treatments Marketed for Cancer

  • FDA Warns of Unapproved Marijuana-Based Treatments Marketed for Cancer

FDA Warns of Unapproved Marijuana-Based Treatments Marketed for Cancer

Alongside those warning letters, FDA published the results of tests that showed that numerous products contained less CBD and more THC than the companies claimed.

Several companies now selling CBD-based medical products have received warning letters from the FDA accusing them of advertising their products as effective cancer treatments without scientific evidence to back them up, reports cannabis activist Tom Angell.

According to the press release, the four companies that received warning letters are Greenroads Health, Natural Alchemist, That's Natural!

Stanley Brothers Social Enterprises, in Colorado Springs, says: '[C] urrent studies have reported that CBD is showing promise in how oncologists are looking to treat breast, glioma, Leukemia, thyroid, colon and lung cancer.' It also brands its hemp oil as "anti-tumoral".

Both marijuana and its cannabinoid components are considered Schedule I drugs under the Controlled Substances Act (CSA), meaning that in the federal government's view they have "no now accepted medical use" and a "high potential for abuse".

The Food and Drug Administration warned companies not to promote marijuana-based products saying that these can cure cancer. The effort has included the issuing of 90 warning letters in the past 10 years, including more than a dozen this year, to companies using such claims to market hundreds of products.

The companies were likely basing their health claims on a small number of animal and cell studies suggesting that CBD and other marijuana components may be able to damage or kill cancer cells. Any sells and its products will be treated like others "that make unproven claims to shrink cancer tumors", the FDA Commissioner Dr. Scott Gottlieb said in a statement.

The agency said in a statement that it has grown increasingly concerned about the growing number of products being marketed as treatments for serious diseases like cancer. "When people are allowed to illegally market agents that deliver no established benefit they may steer patients away from products that have proven, anti-tumor effects that could extend lives", Gottlieb said. The FDA is responsible for regulating the manufacturing, marketing, and distribution of foods and drugs. "We support sound, scientifically-based research using components derived from marijuana, and we'll continue to work with product developers who are interested in bringing safe, effective, and quality products to market".

The agency has requested responses from the companies that would address how the violations will be corrected.

The FDA has not approved CBD oil in any product for any indication. These have 15 working days to inform the Administration with their response in front of the statement.

According to the DEA's website, that category is reserved for drugs for which there are no now accepted medical uses. "So if a consumer happens upon a website or a social media site and they see that this product is marketed as a natural cure for cancer or a natural treatment for cancer, they should be very skeptical, because unless that product has been evaluated by FDA, there's no reason to believe it's safe or effective for that use".

The FDA explains to the general public that unlike most of the other medicinal products that are FDA approved, these products have not gone through the process of FDA review and approval that is a rigorous analysis and evaluation of the drug's process of development through controlled clinical trials.